Koch, R, de la Cruz, F.Historical aspects and overview of research on phenylketonuria. Ment Retard Dev Disabil Res Rev
1999; 5: 101–3.
Woolff, OH, Smith, I, Carson, N, Graham, PJ, Kromrower, GM, Turnbull, AC, Clayton, BE, Mahler, R, Sutherland, I.
Routine neonatal screening for phenylketonuria in the United Kingdom 1964–1978. BMJ (Clin Res Ed)
1981; 282: 1680–4.
Waisbren, S, Schnell, RR, Levy, HL. Diet termination in children with phenylketonuria: a review of psychological assessments used to determine outcome. J Inherit Metab Dis
1980; 3: 149–53.
Howell, DC. Statistical Methods for Psychology (4th edn). Duxbury Press, 1997.
Brown, MCJ, Guest, JF. Economic impact of feeding a phenylalanine restricted diet to adults with previously untreated phenylketonuria. J Intellect Disabil Res
1999; 43: 30–7.
Increased life expectancy in people with untreated phenylketonuria. J Intellect Disabil Res
1998; 42: 97–9.
Hoskin, RG, Sasitharan, T, Howard, R.
The use of a low phenylalanine diet with amino acid supplement in the treatment of behaviour problems in a severely mentally retarded adult female with phenylketonuria. J Intellect Disabil Res
1992; 36: 183–91.
Yannicelli, S, Ryan, A.
Improvements in behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine restricted diet: a national survey. J Inherit Metab Dis
1995; 18: 131–4.
Fitzgerald, B, Morgan, J, Keene, N, Rollinson, R, Hodgson, A, Dalrymple-Smith, J. An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability. J Intellect Disabil Res
2000; 44: 53–9.
Koch, R, Moseley, K, Ning, J, Romstad, A, Guldberg, P, Guttler, F.
Long-term beneficial effects of the pheylalanine-restricted diet in late-diagnsoed individuals with phenylketonuria. Mol Genet Metab
1999; 67: 148–55.